Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits

By Fujimoto S.   Ohashi M.   Hiramoto A.   Inoue Y.   Nagai K.   Shiokawa H.   Itoh T.  

European Journal of Pharmacology, Vol. 353, Iss. 2, 1998-07 ,pp. : 239-246

Elsevier

Access to resources Recommend Favorite

Investigation of the vasorelaxant effects of 3-(5′-hydroxymethyl-2′-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft

By Berkan Ocal   Bagcivan Ihsan   Kaya Tijen   Yildirim Kemal   Yildirim Sahin   Doğan Kasım  

Canadian Journal of Physiology and Pharmacology, Vol. 85, Iss. 5, 2007-05 ,pp. : 521-526

NRC Research Press

Access to resources Recommend Favorite

Sildenafil and T-1032, phosphodiesterase type 5 inhibitors, showed a different vasorelaxant property in the isolated rat aorta

By Mochida H.   Inoue H.   Takagi M.   Noto T.   Yano K.   Kikkawa K.  

European Journal of Pharmacology, Vol. 440, Iss. 1, 2002-04 ,pp. : 45-52

Elsevier

Access to resources Recommend Favorite

Vasorelaxant effect of harman

By Shi C.-C.   Chen S.-Y.   Wang G.-J.   Liao J.-F.   Chen C.-F.  

European Journal of Pharmacology, Vol. 390, Iss. 3, 2000-03 ,pp. : 319-325

Elsevier

Access to resources Recommend Favorite

Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function

By Estrade M.   Grondin P.   Cluzel J.   Bonhomme B.   Doly M.  

European Journal of Pharmacology, Vol. 352, Iss. 2, 1998-07 ,pp. : 157-163

Elsevier

Access to resources Recommend Favorite